DNA Probes-Based Diagnostics - A Worldwide Market Review

NEW YORK, Jan. 29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

DNA Probes-Based Diagnostics - A Worldwide Market Review

http://www.reportlinker.com/p0164348/DNA-Probes-Based-Diagnostics---A-Worldwide-Market-Review.html

DNA probes-based diagnostics is an emerging application area in the in-vitro diagnostics industry. DNA probes, popular across the medical diagnostics industry, determine the presence of a suspected disease caused by an organism or pathogen. Based on the amount of target DNA present, probes can be used either directly to detect target DNA, or indirectly target DNA through amplification that creates a number of copies of specific nucleotide. Increased automation of diagnostic tests, discovery of new diagnostic markets, rising investments in pharmaceutical and pharmacogenomics research, and advancements in DNA array technologies are major growth facilitators for the DNA probes-based diagnostic products market.

In the area of molecular in-vitro diagnostics, DNA based diagnostics represent the most attractive, and fast growing clinical diagnostics technology primarily due to high levels of reliability, sensitivity, and rapidity. Numerous technology breakthroughs in the area of DNA diagnostics include PCR-based techniques, DNA microarrays and microfluidics, fluorescent in situ hybridization (FISH), SNP detection, and DNA nanotechnology, among several others. Breaking from the realm of research, current applications of DNA diagnostics are becoming widespread, with millions of samples from blood, hair and tissues, being analyzed for the positive identification of pathogens and diseases.

These and other market data and trends are presented in "DNA Probes-based Diagnostics: A Worldwide Market Review" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

DNA PROBES-BASED DIAGNOSTICS BMR-1148

CONTENTS

1. METHODOLOGY 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3

2. GLOBAL MARKET OVERVIEW AND OUTLOOK 4

DNA Probes: Robust Growth Ahead 4

Growth Drivers 4

Growth Inhibitors 4

Genetic Profiling of Pathogens: A Road Less Traveled 5

Roche's Entry into the Hall of Molecular Fame 5

DNA Technology: An Evolutionary Scan 6

Opportunities 7

3. MARKET TRENDS/ISSUES 7

DNA Tests: Finding Use in Numerous Applications 7

World's Aging Population Drives the Popularity of DNA-Probe Tests 8

Reimbursements: "Under the Umbrella" 8

Evolution of New & Virulent Infectious Agents 8

The Enlightened Consumer of the 21st Century 9

Challenges In Widespread Deployment of DNA Based Diagnostics 9

Miniaturization: An Uphill Task 9

Improvements in Assay Capabilities 10

Information Handling & Processing: The Soft Side of Diagnostics 10

Integration: The Ultimate Challenge 10

United States: Unraveling the Country's Edge in DNA based

Diagnostics 11

4. PRODUCT FACTS 11

Infectious Diseases 11

Cancer 12

Genetic Predisposition 12

Identity/Forensics 12

Molecular HLA Testing 12

Other Diagnostic Applications 12

5. MOLECULAR DIAGNOSTICS - A PRIMER 13

Implications for Clinical Diagnostics 13

Implications for Clinical Diagnostics 13

Need of the Hour 13

Molecular Diagnostics: Marking the Convergence of Numerous

Technologies 14

Impact of the Human Genome Project 14

Molecular Diagnostics: Domain of the Developed Countries 14

"Tailored Patient Management": An Epitomized Future of

Molecular Diagnostics 14

Futuristics: A Rumination 15

6. CORPORATE DEVELOPMENTS 16

Genzyme Enters into Licensing Agreement with Moffitt Cancer

Center 16

Roche Diagnostics Receives Approval for Elecsys Anti-HCV Assay 16

bioMerieux and FIND Ink Memorandum of Understanding 16

BD Establishes Second Production Facility in China 16

Beckman Coulter Bags Rights to Hepatitis C Virus Test from

Siemens 17

Affymetrix Enters into Partnership with Pathwork Diagnostics 17

Luminex Signs Distribution and Sales Agreement with Abbott 17

Gen-Probe to Acquire Innogenetics 18

Biocept to Introduce I.D.Rh(D) 18

Luminex Molecular Introduces New xTAG™ Respiratory Viral Panel 19

Gen-Probe Introduces Aptima HPV Assay in Europe 19

Genzyme Genetics Introduces Prenatal Diagnosis and Carrier

Testing 20

Affymetrix Launches New Cytogenetic Solution 20

Siemens Acquires Dade Behring 20

Sorenson Genomics Acquires Identigene 20

BioServe Takes Over Genomics Collaborative 21

QIAGEN to Merge With eGene 21

3M Enters into Collaboration with Gen-Probe 22

Luminex Corporation Completes Acquisition of Tm Bioscience 22

Ipsen and bioMerieux Enter into Theragnostics Agreement 23

Celera Acquires Atria Genetics 23

Celera Acquires Berkeley HeartLab 23

Beckman Coulter Enters into Partnership 24

Affymetrix Partners with IPSOGEN for In-Vitro Diagnostic

Cancer Testing 24

Siemens Medical Solutions Acquires Bayer's Diagnostic Division 24

Genetic Solutions and Catapult Merge to Establish Catapult

Genetics 25

Gen-Probe and Millipore Ink Agreement to Market MTC-NI Test 25

QIAGEN Acquires Digene Corporation 26

bioMerieux Unveils VIDAS C 26

bioMerieux Unveils NucliSENS EasyQ HPV 26

bioMerieux Introduces VIDAS® NT-proBNP 26

Abbott Molecular Rolls Out Six DNA Probes 27

7. MAJOR PLAYERS 27

Abbott Laboratories (US) 27

Affymetrix, Inc. (US) 27

Becton, Dickinson & Company (US) 28

Beckman Coulter, Inc. (US) 28

bioMerieux (France) 28

Celera Group (US) 28

Gen-Probe Incorporated (US) 28

Genzyme Corporation (US) 28

Luminex Molecular Diagnostics (Canada) 29

QIAGEN (US) 29

Roche Diagnostics (Switzerland) 29

Siemens Healthcare Diagnostics, Inc. (US) 29

8. MARKET ANALYTICS 30

9. THE UNITED STATES 37

10. CANADA 39

11. JAPAN 40

12. EUROPE 41

a. France 43

b. Germany 44

c. Italy 45

d. The United Kingdom 46

e. Rest of Europe 47

13. ASIA PACIFIC 48

14. LATIN AMERICA 49

EXHIBITS

Table 1: Global DNA Probes-based Diagnostic Market by Region

for the Period 2007-2015 (Sales in US$ Million)

Table 2: Percentage Breakdown of Global DNA Probes-based

Diagnostic Market by Region for the Years 2008 & 2012

Table 3: Global DNA Probes-based Diagnostics (Infectious

Disease Diagnosis) Market by Region for the Period 2007-2015

(Sales in US$ Million)

Table 4: Percentage Breakdown of Global DNA Probes-based

Diagnostics (Infectious Disease Diagnosis) Market by Region

for the Years 2008 & 2012

Table 5: Global DNA Probes-based Diagnostics (Cancer

Diagnosis) Market by Region for the Period 2007-2015 (Sales

in US$ Million)

Table 6: Percentage Breakdown of Global DNA Probes-based

Diagnostics (Cancer Diagnosis) Market by Region for the Years

2008 & 2012

Table 7: Global DNA Probes-based Diagnostics (Genetic

Predisposition Diagnosis) Market by Region for the Period

2007-2015 (Sales in US$ Million)

Table 8: Percentage Breakdown of Global DNA Probes-based

Diagnostics (Genetic Predisposition Diagnosis) Market by

Region for the Years 2008 & 2012

Table 9: Global DNA Probes-based Diagnostics

(Identity/Forensics Diagnosis) Market by Region for the Period

2007-2015 (Sales in US$ Million)

Table 10: Percentage Breakdown of Global Identity/Forensics

Market by Region for the Years 2008 & 2012

Table 11: Global DNA Probes-based Diagnostics (Molecular HLA

Testing) Market by Region for the Period 2007-2015 (Sales in

US$ Million)

Table 12: Percentage Breakdown of DNA Probes-based Diagnostics

(Molecular HLA Testing) Market by Region for the Years 2008 &

2012

Table 13: Global Market for DNA Probes-based Diagnostics in

Other Types of Diagnosis by Region for the Period 2007-2015

(Sales in US$ Million)

Table 14: Percentage Breakdown of Global Market for DNA

Probes-based Diagnostics in Other Types of Diagnosis by

Region for the Years 2008 & 2012

Table 15: DNA Probes-based Diagnostic Market by Application in

the US: 2007- 2015 (Sales in US$ Million)

Table 16: Percentage Breakdown of DNA Probes-based Diagnostic

Market by Application in the US for the Years 2008 & 2012

Table 17: DNA Probes-based Diagnostic Market by Application in

Canada: 2007-2015 (Sales in US$ Million)

Table 18: Percentage Breakdown of DNA Probes-based Diagnostic

Market by Application in Canada for the Years 2008 & 2012

Table 19: DNA Probes-based Diagnostic Market by Application in

Japan: 2007- 2015 (Sales in US$ Million)

Table 20: Percentage Breakdown of DNA Probes-based Diagnostic

Market by Application in Japan for the Years 2008 & 2012

Table 21: DNA Probes-based Diagnostic Market by Region in

Europe: 2007- 2015 (Sales in US$ Million)

Table 22: Percentage Breakdown of DNA Probes-based Diagnostic

Market by Region in Europe for the Years 2008 & 2012

Table 23: DNA Probes-based Diagnostic Market by Application in

Europe: 2007-2015 (Sales in US$ Million)

Table 24: Percentage Breakdown of DNA Probes-based Diagnostic

Market by Application in Europe for the Years 2008 & 2012

Table 25: DNA Probes-based Diagnostic Market by Application in

France: 2007- 2015 (Sales in US$ Million)

Table 26: Percentage Breakdown of DNA Probes-based Diagnostic

Market by Application in France for the Years 2008 & 2012

Table 27: DNA Probes-based Diagnostic Market by Application in

Germany: 2007-2015 (Sales in US$ Million)

Table 28: Percentage Breakdown of DNA Probes-based Diagnostic

Market by Application in Germany for the Years 2008 & 2012

Table 29: DNA Probes-based Diagnostic Market by Application in

Italy: 2007-2015 (Sales in US$ Million)

Table 30: Percentage Breakdown of DNA Probes-based Diagnostic

Market by Application in Italy for the Years 2008 & 2012

Table 31: DNA Probes-based Diagnostic Market by Application in

the UK: 2007- 2015 (Sales in US$ Million)

Table 32: Percentage Breakdown of DNA Probes-based Diagnostic

Market by Application in the UK for the Years 2008 & 2012

Table 33: DNA Probes-based Diagnostic Market by Application in

Rest of Europe: 2007-2015 (Sales in US$ Million)

Table 34: Percentage Breakdown of DNA Probes-based Diagnostic

Market by Application in Rest of Europe for the Years 2008 &

2012

Table 35: DNA Probes-based Diagnostic Market by Application in

Asia Pacific: 2007-2015 (Sales in US$ Million)

Table 36: Percentage Breakdown of DNA Probes-based Diagnostic

Market by Application in Asia Pacific for the Years 2008 &

2012

Table 37: DNA Probes-based Diagnostic Market by Application in

Latin America: 2007-2015 (Sales in US$ Million)

Table 38: Percentage Breakdown of DNA Probes-based Diagnostic

Market by Application in Latin America for the Years 2008 &

2012

COMPANIES PROFILED

To order this report:

Diagnostics Industry: DNA Probes-Based Diagnostics - A Worldwide Market Review

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

SOURCE Reportlinker

21%

more press release views with 

Request a Demo